T. Shen et al., STABILITY OF THE VASOPRESSIN V-2 RECEPTOR-ADENYLYL CYCLASE SYSTEM IN RAT-KIDNEY, European journal of pharmacology, 341(1), 1998, pp. 87-94
In the Brattleboro rat with diabetes insipidus vasopressin V-2 recepto
r mRNA and the mRNA of various adenylyl cyclase (AC) isoforms are mode
rately reduced compared with those of normal rats. In the present stud
y renal vasopressin V-2 receptor mRNA was modestly higher (by 34%), as
was expression of AC 5, 6 and 9 mRNAs (up to 22% greater), in BDI rat
s treated with the vasopressin V-2 receptor agonist desamino-[Arg(8)]
vasopressin than in untreated control. AC 4 mRNA was decreased by 17%
following desamino-[Arg(8)] vasopressin treatment. While the stimulato
ry Gs cy mRNA was little affected by the desamino-[Arg8(]) vasopressin
treatment, two of the inhibitory G proteins were raised (G alpha i-2
by 54% and G alpha i-3 by 57%). Treatment of Sprague-Dawley rats with
a specific vasopressin V-2 receptor antagonist (SR 121463A) was not as
sociated with any marked changes in mRNA expression. These results ind
icate that the vasopressin V-2 receptor adenylyl cyclase system mediat
ing the antidiuretic response to vasopressin is relatively stable. The
Gi proteins may be involved in the stabilizing mechanism, (C) 1998 El
sevier Science B.V.